The size of the Plasma Protein Therapeutics Market in the Middle East & Africa has been valued at USD 1197.23 Million in 2022 and held the most dominant share in the global market and is estimated to reach USD 1840.06 Million by the end of 2027, growing at a CAGR of 8.976% from 2022 to 2027.
Recent years have witnessed the increased usage of plasma proteins in medical applications. The advancements in technology have made the process for fractionating the protein from plasma more efficient and cost-saving and is a huge boost to the market. Reports suggest that half of the global blood donors are from high-income countries, constituting only 18% of the global population. Rising awareness among individuals regarding the significance of blood donations and government initiatives helped the market propel the market significantly.
Plasma is a protein-rich fluid that is responsible for blood clotting and providing immunity towards diseases. Isolation of these proteins from plasma can help provide medical therapies, which include immune deficiencies, autoimmune, neurological, and bleeding disorders. Plasma protein therapies help replace the deficient or missing proteins and help the individual lead a normal life. The therapies involve either the injection or infusion of biological medicines to treat life-threatening genetic and chronic diseases.
The introduction of new plasma-derived therapies in the market is the key driving force for the market, along with a host of other drivers that include increasing prevalence of life-threatening diseases involving neurological or immune systems like chronic inflammatory demyelinating polyneuropathy (CIPD), Idiopathic thrombocytopenic purpura (ITP) and other diseases such as Rabies, Hepatitis A&B, Tetanus and varicella. However, there are few hurdles the market must overcome to sustain in the future which including reimbursement issues, stringent regulatory policies, and complexities in manufacturing.
This research report on the Middle East and Africa Plasma Protein Therapeutics Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By Country:
Major companies leading in the Middle East & Africa Plasma Protein Therapeutics Market profiled in this report are Grifols, CSL Behring, Baxter, Krdrion, China Biologics, Octapharma, Chendu Inst, and Shire Plc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modeling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Immunoglobulins
5.1.2 Albumin
5.1.3 Coagulation Factors
5.1.4 Alpha-1 proteinase inhibitor
5.1.5 Others
5.2 By Application
5.2.1 Hemophilia
5.2.2 Primary Immunodeficiency Disorder
5.2.3 Idiopathic Thrombocytopenic Purpura
5.2.4 Secondary Immunodeficiency
5.2.5 Others
6. Geographical Analysis
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 CSL Behring
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Baxter
8.3 Biotest
8.4 China Biologics
8.5 Grifols
8.6 Kedrion
8.7 Octapharma
8.8 Shire Plc.
8.9 Chengdu Inst.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.